Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,013,674
+$639,734 QoQ
Shares Held
19,924
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,314
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. ABBV ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,013,674 | 19,924 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,373,940 | 20,111 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $5,198,375 | 22,751 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $4,457,145 | 19,250 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $3,913,240 | 21,082 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,368,072 | 20,848 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,602,512 | 20,273 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,951,772 | 20,011 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,506,383 | 20,443 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,812,809 | 20,938 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,210,668 | 20,718 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $3,112,074 | 20,878 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,974,299 | 22,076 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $3,725,592 | 23,377 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $3,622,972 | 22,418 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,933,427 | 21,857 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $3,389,737 | 22,132 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,540,806 | 21,842 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,977,175 | 21,988 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $2,435,488 | 22,578 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $2,544,312 | 22,588 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $2,400,103 | 22,178 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $2,332,655 | 21,770 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $1,883,185 | 21,500 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,067,670 | 21,060 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $987,346 | 12,959 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||